Research Use Only · Dosing data compiled from published literature · Not for human or veterinary use

SLU-PP-332 Dosage & Reconstitution

ERR pan-agonist. Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: preclinical.

1Set Up Your Mix

1 mg/mL · 1000 mcg/mL

Your Answer — SLU-PP-332

5 mg in 5 mL
25Draw To This Line
0.25That's This Many mL
20Doses In The Vial
0102030405060708090100 U-100 syringe · 1 mL · 100 units draw to 25
5 mg ÷ 5 mL = 1 mg/mL  →  250 mcg ÷ 1 mg/mL = 0.25 mL  →  × 100 = 25 units
Looks good. Draw to 25 units on a 1 mL syringe. That is an easy amount to measure, and this vial gives you 20 doses.
When to dose
Time of dayAny time of day. Weekly compounds should be kept to the same day each week.
FoodWith or without food — it makes no meaningful difference.

These are long-acting and reach steady state over weeks, so a single day’s timing has little effect. Consistency matters more than the hour.

2Week-By-Week Plan — SLU-PP-332

Start low, work up
WhenDoseHow OftenHow Many mLDraw ToNumber Of DosesPeptide Used
Weeks 1–2 250 mcg daily 0.25 mL 25 u 14 3.5 mg
Week 3 onward
per 4 weeks from here on
500 mcg daily 0.5 mL 50 u 28 14 mg
Time until the top dose
2 weeks
Peptide used getting there
3.5 mg
Vials you'll need
1 × 5 mg
Once you're at the top dose
14 mg / 4 wk · 2.8 vials
Where this plan came from
Built from this peptide's dose range
Where this came from: Built from the doses listed for this peptide below — start at the lowest and step up, using the studies cited on this page. Nobody publishes a week-by-week plan for this peptide, so we built one: the doses are the researched ones shown below, and we simply put them in order from lowest to highest. Treat it as a starting point, not an official schedule.

3Common Doses — SLU-PP-332

worked out for your mix
LevelDoseHow OftenHow Many mLDraw ToDoses In Vial
Research study dose50 mg/kg weight-baseddaily Set by body weight — can't be turned into a single amount to draw
Community reported 250 mcg 1× daily 0.25 mL 25 u 20 doses
Community reported upper 500 mcg 1× daily 0.5 mL 50 u 10 doses
Please read this. These numbers come from published research. They are here as reference, not as instructions. A lot of them come from lab studies rather than studies in people, and some of these peptides have never been given to a person at all.

About SLU-PP-332

Metabolic / Incretin
Also known as
ERR pan-agonist
Class
Metabolic / Incretin
Route
Subcutaneous
Half-life
Short
Evidence tier
Preclinical

An estrogen-related receptor pan-agonist described as an exercise mimetic in preclinical models. Not a peptide, no human data of any kind. Reported doses below are the weight-based research figures, given raw rather than converted, because a human-equivalent conversion is not supported.

Buy SLU-PP-332

Common Questions — SLU-PP-332

How much bacteriostatic water do I add to a 5 mg vial of SLU-PP-332?

Adding 5 mL of bacteriostatic water to a 5 mg vial gives 1 mg/mL. That is the mix every number on this page is worked out from — change the water figure in the calculator and all the draw amounts update.

What dose of SLU-PP-332 is used in research?

Published and reported figures for SLU-PP-332 run from 250 mcg to 500 mcg, typically 1× daily. This site lists each figure with the source it came from rather than giving a single recommended number.

How many units on the syringe is a 250 mcg dose of SLU-PP-332?

At 1 mg/mL, a 250 mcg dose is 25 units on a 1 mL U-100 insulin syringe. One vial at that mix gives about 20 doses.

How strong is the evidence behind these SLU-PP-332 doses?

SLU-PP-332 is graded preclinical. Laboratory and animal data only. No human dosing trials have been published. We grade every compound on this site so you can weigh the numbers accordingly — the full method is on our editorial policy page.

Where These Numbers Come From

Preclinical — Preclinical and in-vitro data only — no human dosing trials
An ERR agonist that enhances exercise capacity Billon C, et al. Journal of Pharmacology and Experimental Therapeutics / Cell Reports Medicine, 2023–24
The running-capacity study that generated all interest in this compound.
Find on PubMed ↗

Newest Studies —

Not reviewed by us. This list is pulled straight from Europe PMC as papers are published. Nobody has checked whether these are any good, or whether they change anything above. The dose numbers on this page only ever change after a person reviews the evidence.

Other metabolic / incretin peptides

Compounds in the same class, or browse the full catalogue.

5-Amino-1MQ

A small-molecule NNMT inhibitor rather than a true peptide. Research data show reduced adiposity in diet-induced obesity models. D…

All 72 peptides

Every compound compared in one table: dose range, how often, half-life and evidence tier.

Need this on one page to print, screenshot or send?

Make a dose card →